Concepedia

Fengfeng Xie

FX

5

Publications

197

Citations

5

H-Index

2015

Active since

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Jinan University

Fengfeng Xie is an author at First Affiliated Hospital of Wenzhou Medical University specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2015–2022

5

Publications

5

Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752

Xiuxiu Chen, Li-Hua Gong, Rongying Ou et al. · Gynecologic Oncology · 2015 · 69 citations

, , +7

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer

Xiuxiu Chen, Fengfeng Xie, Xiu-Jie Zhu et al. · Oncotarget · 2015 · 61 citations · Full text

Berberine Ameliorates Insulin Resistance by Inhibiting IKK/NF-κB, JNK, and IRS-1/AKT Signaling Pathway in Liver of Gestational Diabetes Mellitus Rats

Anyang Li, Lin Cong, Fengfeng Xie et al. · Metabolic Syndrome and Related Disorders · 2022 · 24 citations

Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer.

Fengfeng Xie, Shi-Shi Pan, Rongying Ou et al. · PubMed · 2015 · 22 citations · Full text

, , +15

Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.

Xiaoxiu Huang, Fengfeng Xie, Li-Jiao Hou et al. · PubMed · 2017 · 21 citations

Rows per page

1–5 of 5